Published 22:37 IST, June 3rd 2020

WHO Executive Group allows resuming solidarity trial on HCQ, a week after pausing it

In a major decision, World Health Organisation (WHO)'s Executive Group, on Wednesday has allowed resuming all solidarity trials, including on Hydroxychloroquine

Follow: Google News Icon
  • share
null | Image: self
Advertisement

In a major decision, World Health Organisation (WHO)'s Executive Group, on Wednesday has allowed resuming all solidarity trials, including one on Hydroxychloroquine, anunced WHO director Dr.Tedros. He added that based on available mortality data, members of committee recommended that re are reasons to modify trial protocol. So far, more than 3500 patients have been recruited in 35 countries for solidarity trial.

Coronavirus Live Updates: Cases in India at 2,07,615 - 1,01,497 active & 1,00,302 cured

Advertisement

WHO resumes HCQ trials

ICMR disagrees with WHO's suspension of HCQ trials, cites 'vast difference' in dos

WHO pauses HCQ trial

On May 25, same group had decided to temporarily pause Hydroxychlorine (HCQ) trial while data collected so far is reviewed. He added that Executive Group's solidarity trial comprising of 10 countries will adequately evaluate potential benefits and harms from this drug. Clarifying that or arms of trial were continuing, he added that drugs hydroxychloroquine and chloroquine were generally safe for treating patients of autoimmune diseases or malaria.

Advertisement

WHO Executive Group pauses solitary trial on HCQ to review data as ICMR expands its us

ICMR disagrees with WHO on HCQ

In response to move, India's apex science body - Indian Council of Medical Research (ICMR) wrote to WHO expressing ir disagreement over suspension of anti-malarial drug. ICMR stated that primary point of ir difference in opinion with WHO was dos standards between Indian and international trials which bodies said would explain efficacy issues of HCQ in treating COVID-19 patients. ICMR recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in n-COVID-19 hospitals, frontline staff on surveillance duty in containment zones, and paramilitary/police personnel involved in coronavirus infection-related activities, but t for treating COVID-19.

WHO chief Tedros Adham reminds importance of clean hands on Hand Hygiene Day

Advertisement

Dr. Harsh Vardhan takes charge as WHO Executive Board chairman

This development comes days after India's Union Health Minister Dr Harsh Vardhan took over as WHO Executive Board Chairman at 147th session of WHO Executive Board, held virtually. India was among 10 nations that were elected by 73rd World Health Assembly to Executive Board of WHO for a period of three years. same board met on Saturday and has decided to pause trial as data gets reviewed by Safety Monitoring Board and w has allowed resuming trials.
 

22:37 IST, June 3rd 2020